IL1B and chondrosarcoma: Relative to the levels for IL-1β-treated human chondrosarcoma cell line SW1353, the expressions of MMP-1, MMP-3 and MMP-13 were decreased dose dependently in the 20 μg/mL CZE and 0.4 μg/mL linarin treatment (Figure 7A).